{"nct_id":"NCT02017717","title":"A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2014-02-07","start_date_type":"ACTUAL","primary_completion_date":"2019-06-17","primary_completion_date_type":"ACTUAL","completion_date":"2024-06-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}